Recombinant soluble GPC3 interferes with HCC cell growth, suggesting that GPC3 may compete with cell surface GPC3 to bind GPC3-interacting molecules or may block GPC3-targeted therapies. This evidence concerns the gene GPC3 and hepatocellular carcinoma.